2024    2023    2022    2021    2020    2019    2018    2017    2016   

2021

Articles

141 - 

Clinical trials vigilance: Comparison of sponsor and investigator's imputabilities of serious adverse events in a randomized, double-blinded study

A. Prioul, C. Mouchel, C. Lefeuvre, E. Polard, E. Bellissant et al.

Fundamental & Clinical Pharmacology, 2021, 35, pp.142-142.

 

142 - 

Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms

Charlotte Pronier, Arnaud Gacouin, Gisèle Lagathu, Yves Le Tulzo, Jean-Marc Tadié et al.

Journal of Clinical Virology, 2021, 136, pp.104761.

DOI : https://doi.org/10.1016/j.jcv.2021.104761

Pubmed : 33609934

 

143 - 

Redefining the Classifications of Response to Cardiac Resynchronization Therapy: Results From the REVERSE Study

Michael R Gold, John Rickard, Jean-Claude Daubert, Patrick Zimmerman, Cecilia Linde et al.

JACC: Clinical Electrophysiology, 2021, 7 (7), pp.871-880.

DOI : https://doi.org/10.1016/j.jacep.2020.11.010

Pubmed : 33640347

 

144 - 

An Innovative Biological Model for Ultrasound-Guided Central Venous Access Simulation

Guillaume R Grillet, Pierre M Bouju, E Le Pabic, David J Guinier, James D Norwood et al.

Simulation in Healthcare, 2021, Publish Ahead of Print (5),

DOI : https://doi.org/10.1097/SIH.0000000000000520

Pubmed : 33196608

 

145 - 

Taking kinetic evaluations of degradation data to the next level with nonlinear mixed-effects models

J. Ranke, J. Wöltjen, J. Schmidt, E. Comets

Environments, 2021, 8 (8), pp.71.

DOI : https://doi.org/10.3390/environments8080071

 

146 - 

Hypothermic oxygenated perfusion(HOPE) improves ECD liver graft function and reduces duration of hospitalisation without extra cost: The PERPHO Study

Michel Rayar, Jean-Marie Beaurepaire, Emma Bajeux, Stephanie Hamonic, Thomas Renard et al.

Liver Transplantation, 2021, 27 (3), pp.349-362.

DOI : https://doi.org/10.1002/lt.25955

Pubmed : 33237618

 

147 - 

Moving towards green anaesthesia: are patients’ safety and environmentally friendly practices compatible? A focus on single-use devices

Thibault Reynier, Mathilde Berahou, Pierre Albaladejo, Hélène Beloeil

Anaesthesia Critical Care & Pain Medicine, 2021, 40 (4), pp.100907.

DOI : https://doi.org/10.1016/j.accpm.2021.100907

Pubmed : 34153533

 

148 - 

Data sharing policies of funders of clinical trials in France

P. Rollando, C. Parc, Florian Naudet, J. Gaba

Fundamental & Clinical Pharmacology, 2021, 35, pp.155-156.

 

149 - 

Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort

Fabien Rollot, Mathieu Fauvernier, Zoe Uhry, Sandra Vukusic, Nadine Bossard et al.

Neurology, 2021, 97 (4), pp.e403-e413.

DOI : https://doi.org/10.1212/WNL.0000000000012224

Pubmed : 34011577

 

150 - 

Cumulative effects of therapies on disability in relapsing multiple sclerosis

Fabien Rollot, Romain Casey, Emmanuelle Leray, Marc Debouverie, Gilles Edan et al.

Multiple Sclerosis Journal, 2021, 27 (11), pp.1760-1770.

DOI : https://doi.org/10.1177/1352458520980366

Pubmed : 33403937